Prenatal and postpartum care – as it’s generally practiced in the United States – hasn’t changed much in over 50 years. First developed primarily to diagnose preeclampsia (then called toxemia), prenatal visits include peeing in a cup, weighing mom, and taking her blood pressure, over the course of 12 to 14 prenatal visits, spaced one month apart until the third trimester when visits increase to once a week in the last month. Following delivery, a single postpartum visit at 6 weeks clears mom to resume normal activities and offers birth control (contraceptives).
Innovations and disruptive technologies in maternity care are desperately needed to better prevent, diagnose, and manage hypertensive disorders of pregnancy. Research, development, and implementation of newer models of care are, in some places, starting to be realized.
A one-week postpartum visit is now recommended as part of recognizing the physical and mental challenges in the “4th trimester” – the three months following delivery, especially important for mothers who experienced any kind of hypertension or medical complications. The 4th Trimester Project has developed several valuable resources that can help providers better serve their postpartum patients.
Aspirin, while far from being a cure-all, may help some women prevent or delay the onset of preeclampsia and is more widely prescribed to those at high or moderate risk.
Group care, telehealth, and connected care are models being tested in various settings to provide more customized prenatal care. Read more about those below, under Glossary. More advanced biomarkers are in development that can predict a woman’s risk of preeclampsia or diagnose it more accurately and earlier than traditional methods. We are active proponents of these innovations in obstetric care on Capitol Hill and elsewhere.
The Preeclampsia Foundation plays an active and vocal role in these innovations. Our goal is to disrupt inadequate healthcare practices, improve the patient experience, and eliminate disparities and health inequities.
Often under the brand name Centering Pregnancy®, group care allows a patient to meet with a group of other patients with similar due dates to share and learn relevant information, check blood pressure, and address medical and social services needs. The woman has time alone with her maternity care provider to check fetal heart rate and discuss any unique or sensitive issues. This ad hoc community often create bonds that extend beyond delivery and encourage peer support for parenting and newborn issues.
Telehealth allows a patient to meet with her healthcare provider through a phone or video call. The patient checks her own vital signs such as blood pressure and shares this information with her provider. Under the COVID-19 pandemic, we saw a surge in telehealth usage as regulations were loosened and women were either afraid to physically go to hospitals or clinics and providers sought to minimize unnecessary exposure.
Connected care usually means a patient has a reduced number of individual appointments and in between uses remote technology to assess her BP and other vital signs which are often automatically transmits to her provider. A nurse or some system of assessment ensures those data are monitored and appropriate responded to. An example is this program in Louisiana.
Research, development and marketing of biomarkers to predict and diagnose preeclampsia have accelerated in recent years. In the United Kingdom and other areas of the world, commercial tests are already on the market. Utilizing proteomics, metabolomics, and other analytes, molecular biomarkers have the potential to finally define preeclampsia as one or more specific conditions, rather than its current status as a syndrome because of the loose collection of “clues” that makes diagnosis and treatment often ambiguous, even to experts. Sign a petition to advocate for biomarker development and adoption.
Donating appreciated securities, including stocks or bonds, is an easy and tax-effective way for you to make a gift to the Preeclampsia Foundation.
PUBLIC POLICY PRIORITIES The Preeclampsia Foundation's advocacy priorities are focused on supporting efforts to reduce maternal and infant illness and death due to preeclampsia, HELLP syndrome, a...
We did it! Act2SaveMoms has become a law December 22, 2018: This is a great day for preeclampsia and the beginning of the end of needless deaths. Late last night, President Trump...
Want to impact how your state and our nation handles maternity care?
RECOGNITION & RESPONSE IS CRITICAL Less than half of well-educated women know the signs and symptoms of preeclampsia. And still others may not share their symptoms with their healthcare pro...